Abstract
Pancreatic cancer is responsible for 2% of all types of diagnosed cancers in Brazil and the only curative treatment available is the surgical removal of the tumor in early stages of the disease. Prevention, early detection and treatment are poor, facing serious problems and asking for new identification methods for disease diagnosis and prognosis. While somatic mutation of some genes (KRA…